2. The problem of the consumer: Venous thromboembolism (VTE)
3.
4. The product
"Anti-clot" complies with the "Russian clinical guidelines for the diagnosis and treatment of chronic
diseases of the veins" that have been developed by the Association of Phlebology Russia and approved
by the Ministry of Health of Russia. High efficiency "ANTI-clot" is confirmed by the experts of the State
Research Medical Institute (Samara, Russia)
5.
6. Stage of the project
* mass production of the product is started
* product is patented
* sales are started
* an online store created
Financial indicators of the project (in Russia , 1-st year)
* the value of the necessary investment $ 50,000
* the volume of sales in the year (units) 4 500
* the volume of sales in the year $ 477,000
* NPV (discount rate = 30%) $ 207,370
* IRR проекта 414 %
* benefit - cost ratio 314 %
7. Team of the project
RUBOCHKIN Vladimir -- CEO of project, electronic engineer, patent holder
GUMEROW Ildus – scientific director, phd, phlebologist
GUMEROW Shamil – manager, marketer
CONTACTS:
RUBOCHKIN Vladimir
Tel: +7-987-634-3221
E-mail: v_rubochkin@mail.ru
Skype: v_rubochkin
URL: www.anti-clot.com